Evidence map›Paper›PMID 41530150›Full record

ArticleNature communications2026

Intranasal unadjuvanted LcrV boosts parental Yersinia OMV primed lung immunity against pneumonic plague in mice.

Saugata Majumder, Shreya Das, Mohd Saqib, McKenzie Van der Veer, Moe Acee, Wei Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Saugata MajumderDepartment of Immunology and Microbial Disease, Albany Medical College, Albany, NY, USA.
Shreya DasDepartment of Immunology and Microbial Disease, Albany Medical College, Albany, NY, USA.
Mohd SaqibDepartment of Molecular and Cellular Physiology, Albany Medical College, Albany, NY, USA.
McKenzie Van der VeerDepartment of Immunology and Microbial Disease, Albany Medical College, Albany, NY, USA.
Moe AceeSkidmore College, Saratoga Springs, NY, USA.
Wei SunDepartment of Immunology and Microbial Disease, Albany Medical College, Albany, NY, USA. sunw@amc.edu.ORCID http://orcid.org/0000-0002-0071-6987

Funding

Yersinia Outer-Membrane-Vesicle Vaccines Against Pneumonic PlagueR01AI162670 · NIAID · ALBANY MEDICAL COLLEGE · PI Wei Sun · 2022 to 2026
$3.4M
NIAID NIH HHS R01 AI162670U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) RO1AI162670
6 · The paper itself

Abstract

Pneumonic plague remains a high-consequence respiratory disease, highlighting the need for vaccines that induce durable lung-localized immunity. We show that intramuscular prime-boost vaccination with Alum-absorbed OMV

Indexed as

Antigens, BacterialLungPlaguePlague VaccinePore Forming Cytotoxic ProteinsYersinia pestisAdministration, IntranasalAlum CompoundsAnimalsAntibodies, BacterialBacterial Outer Membrane ProteinsB-LymphocytesFemaleImmunization, SecondaryImmunologic MemoryInterferon-gammaAlum CompoundsAntibodies, BacterialAntigens, BacterialBacterial Outer Membrane ProteinsInterferon-gammaInterleukin-17Interleukin-4LcrV protein, YersiniaPlague VaccinePore Forming Cytotoxic Proteins

Identifiers

PMID41530150
PMCPMC12905419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.